Pyoderma gangrenosum (PG) is an orphan disease. While research on such disorders is
based on only few randomized multicenter as well as retrospective studies, most of the data …

Pyoderma gangrenosum (PG) is a rare, neutrophilic skin disease. For the purpose of
accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for …

Tumour necrosis factor alpha (TNF-α) is a key molecule of the inflammatory response and
data derived from studies in experimental animal models and humans suggest that TNF-α …

Background The group of autoinflammatory syndromes associated with Pyoderma
gangrenosum, Acne, and Suppurative Hidradenitis are poorly defined and difficult to control …

Background Pyoderma gangrenosum is a serious cutaneous complication seen in
approximately 1% of patients with inflammatory bowel disease (IBD). Oral corticosteroids are …

Pyoderma gangrenosum (PG) is an uncommon inflammatory skin disorder characterized by
neutrophil dysfunction. There are currently no FDA-approved drugs for the treatment of this …

Objectives To record and summarize the overall efficacy and safety of JAKi in various
autoimmune conditions such as alopecia areata (AA), psoriasis vulgaris (PV), psoriatic …

Pyoderma gangrenosum, a dramatic ulcerative skin disease, and Sweet syndrome, a
papular dermatosis, were described independently. It was subsequently shown that they …

Background There are limited large case series of peristomal pyoderma gangrenosum
(PPG), an uncommon cause of recalcitrant peristomal ulceration. Objective We sought to …

Pyoderma gangraenosum : Current Opinion in Rheumatology Pyoderma gangraenosum :
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new …